How Tory by-election candidate Maria Hutchings attacked asylum seekers

The Conservative candidate for the Eastleigh by-election said in 2005: "I don't care about refugees".

The Conservatives' decision to select Maria Hutchings as their candidate for this month's Eastleigh by-election is not one that has been well received by all in the party. As one of Cameron's "A-list" candidates, Hutchings fought and lost the seat in 2010 (Chris Huhne increased his majority from 568 to 3,864) having risen to public attention following her ambushing of Tony Blair live on TV in 2005. To many Tories, she is exactly the kind of political novice that the party should avoid. 

But Hutchings's lack of experience is not the only problem for the Tories; there's also her past bigotry towards immigrants and asylum seekers. After attacking Blair over an alleged plan to close the special needs school her autistic son attended in Essex (Conservative-run Essex County Council later confirmed that no such plan existed), Hutchings was interviewed several times and had the following to say.

With an increasing number of immigrants and asylum seekers then the pot is reduced for the rest of us.

Mr Blair has got to stop focusing on issues around the world such as Afghanistan and Aids in Africa and concentrate on the issues that affect the people of Middle England, like myself who pay the taxes which keep the country going.

In another interview she remarked: 

I don't care about refugees. I care about my little boy and I want the treatment he deserves.

Given David Cameron's commitment to international development and the coalition's plan to increase aid spending from £8.65bn (0.56 per cent of GDP) this year to £11.7bn (0.7 per cent of GDP) in 2014-15, one wonders what Hutchings makes of Cameron's approach. 

If she regrets her 2005 comments, she should at least be required to say so. And if she doesn't, is there really room for her in the "modern, compassionate" Conservative Party that Cameron aspires to build? 

Conservative Eastleigh by-election candidate Maria Hutchings addresses the media at the Conservative headquarters in 2005. Photograph: Getty Images.

George Eaton is political editor of the New Statesman.

Show Hide image

When it comes to the "Statin Wars", it's the patients I pity

Underlying the Statin Wars are two different world-views: the technological and holistic.

September saw the latest salvos in what has become known in medical circles as the Statin Wars. The struggle is being waged most publicly in the pages of Britain’s two leading medical journals. In the red corner is the British Medical Journal, which in 2014 published two papers highly critical of statins, arguing that they cause far more side effects than supposed and pointing out that, although they do produce a modest reduction in risk of cardiovascular disease, they don’t make much difference to overall mortality (you may avoid a heart attack, only to succumb to something else).

In the blue corner is the Lancet, which has long been the publishing platform for the Cholesterol Treatment Trialists’ (CTT) Collaboration, a group of academics whose careers have been spent defining and expounding the benefits of statins. The CTT was infuriated by the BMJ papers, and attempted to force the journal to retract them. When that failed, they set about a systematic review of the entire statin literature. Their 30-page paper appeared in the Lancet last month, and was widely press-released as being the final word on the subject.

A summary would be: statins do lots of good and virtually no harm, and there really is no need for anyone to fuss about prescribing or taking them. In addition, the Lancet couldn’t resist a pop at the BMJ, which it asserts acted irresponsibly in publishing the sceptical papers two years ago.

Where does all this leave the average patient, trying to weigh up the usefulness or otherwise of these drugs? And what about the jobbing doctor, trying to give advice? The view from no-man’s-land goes something like this. If you’ve had a heart attack or stroke, or if you suffer from angina or other conditions arising from furred-up arteries, then you should consider taking a statin. They’re not the miracle pill their proponents crack them up to be, but they do tip the odds a little in your favour. Equally, if you try them and suffer debilitating side effects (many people do), don’t stress about stopping them. There are lots more effective things you could be doing – a brisk daily walk effects a greater risk reduction than any cholesterol-lowering pill.

What of the millions of healthy people currently prescribed statins because they have been deemed to be “at risk” of future heart disease? This is where it gets decidedly murky. The published evidence, with its focus on cardiovascular outcomes alone, overstates the case. In healthy people, statins don’t make any appreciable difference to overall survival and they cause substantially more ill-effects than the literature suggests. No one should be prescribed them without a frank discussion of these drawbacks, and they should never be taken in lieu of making lifestyle changes. Smoking cessation, a healthy diet, regular modest exercise, and keeping trim, are all far more important determinants of long-term health.

Underlying the Statin Wars are two different world-views. One is technological: we can rely on drugs to prevent future health problems. This perspective suffers substantial bias from vested interests – there’s a heck of a lot of money to be made if millions of people are put on to medication, and those who stand to profit make huge sums available to pay for research that happens to advance their cause.

The other world-view is holistic: we can take care of ourselves better simply by living well, and the fetishising of pharmaceutical solutions negates this message. I have great sympathy with this perspective. It certainly chimes with the beliefs of many patients, very few of whom welcome the prospect of taking drugs indefinitely.

Yet the sad truth is that, irrespective of our lifestyles, we will all of us one day run into some kind of trouble, and having medical treatments to help – however imperfectly – is one of mankind’s greatest achievements. In arguing for a greater emphasis on lifestyle medicine, we must be careful not to swing the pendulum too far the other way.

Phil Whitaker’s latest novel is “Sister Sebastian’s Library” (Salt)

This article first appeared in the 20 October 2016 issue of the New Statesman, Brothers in blood